Cross new MA chairman
June 25, 2013
The Board of Medicines Australia
(MA) today announced that it has
appointed Dr Martin Cross as the
new Chair of Medicines Australia.
The move follows the recent
announcement of his departure
from his role as managing director
of Alphapharm (PD 12 Jun).
“Dr Cross has a wealth of
experience in the industry, recently
working in the generics industry
after more than 20 years working
in the innovative industry,” said
interim MA chair Mark Fladrich.
“He is a passionate advocate
for, and supporter of, the sector
in Australia which fits well with
the purpose and objectives of
Medicines Australia.”
Cross was also chair of the
Generic Medicines Industry
Association and Chair of the
Pharmaceutical Industry Council.
He has previously been MD of
Novartis in Australia and a member
of the MA Board, and has also
previously worked over many years
for ICI, Zeneca and AstraZeneca,
another MA member company.
The appointment was welcomed
by the Generic Medicines Industry
Association, with GMiA saying it
looks forward to working with MA
to reduce the cost of medicines
to the govt, ensure access to new
affordable drugs and reform the
intellectual property framework.
The above article was sent to subscribers in Pharmacy Daily's issue from 25 Jun 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Jun 13
Warning: Undefined variable $flipbook_id in
/home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line
1259
Warning: Undefined variable $o_shortcode_atts in
/home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line
1263
Warning: Undefined variable $output in
/home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line
1266
